Top Glove Corporation Bhd. (TGLVY)
USD 1.06
(0.0%)
USD 1.06
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -538 Million MYR | -299.46% |
| 2022 | 354.86 Million MYR | -96.46% |
| 2021 | 10.02 Billion MYR | 357.29% |
| 2020 | 2.19 Billion MYR | 338.13% |
| 2019 | 500.58 Million MYR | -9.64% |
| 2018 | 553.98 Million MYR | 45.68% |
| 2017 | 380.26 Million MYR | -12.05% |
| 2016 | 432.34 Million MYR | 18.54% |
| 2015 | 364.72 Million MYR | 82.23% |
| 2014 | 200.14 Million MYR | -14.1% |
| 2013 | 232.98 Million MYR | -3.25% |
| 2012 | 240.81 Million MYR | 79.42% |
| 2011 | 134.22 Million MYR | -56.08% |
| 2010 | 305.6 Million MYR | 32.57% |
| 2009 | 230.52 Million MYR | 58.23% |
| 2008 | 145.68 Million MYR | 10.23% |
| 2007 | 132.16 Million MYR | 30.44% |
| 2006 | 101.32 Million MYR | 43.88% |
| 2005 | 70.42 Million MYR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -39.5 Million MYR | 108.23% |
| 2024 Q1 | -59.52 Million MYR | 80.7% |
| 2024 Q2 | -60.96 Million MYR | 33.01% |
| 2023 Q3 | -106.99 Million MYR | 25.24% |
| 2023 Q2 | -143.12 Million MYR | 4.35% |
| 2023 FY | -707.83 Million MYR | -299.46% |
| 2023 Q1 | -149.63 Million MYR | -200.92% |
| 2023 Q4 | -308.44 Million MYR | -188.27% |
| 2022 Q4 | -49.72 Million MYR | -219.91% |
| 2022 Q2 | 112.84 Million MYR | -56.69% |
| 2022 Q1 | 260.55 Million MYR | -58.03% |
| 2022 FY | 354.86 Million MYR | -96.46% |
| 2022 Q3 | 41.46 Million MYR | -63.25% |
| 2021 Q4 | 620.8 Million MYR | -76.16% |
| 2021 Q3 | 2.6 Billion MYR | -30.09% |
| 2021 Q2 | 3.72 Billion MYR | 20.3% |
| 2021 Q1 | 3.09 Billion MYR | 109.29% |
| 2021 FY | 10.02 Billion MYR | 357.29% |
| 2020 Q3 | 429.87 Million MYR | 187.79% |
| 2020 Q4 | 1.47 Billion MYR | 244.15% |
| 2020 Q1 | 141.58 Million MYR | 48.97% |
| 2020 FY | 2.19 Billion MYR | 338.13% |
| 2020 Q2 | 149.37 Million MYR | 5.5% |
| 2019 Q1 | 159.79 Million MYR | -3.86% |
| 2019 Q2 | 145.31 Million MYR | -9.06% |
| 2019 Q3 | 104.16 Million MYR | -28.31% |
| 2019 FY | 500.58 Million MYR | -9.64% |
| 2019 Q4 | 95.04 Million MYR | -8.76% |
| 2018 Q3 | 147.33 Million MYR | 15.78% |
| 2018 Q4 | 166.2 Million MYR | 12.81% |
| 2018 Q2 | 127.24 Million MYR | 2.96% |
| 2018 Q1 | 123.58 Million MYR | 22.06% |
| 2018 FY | 553.98 Million MYR | 45.68% |
| 2017 Q1 | 90.92 Million MYR | 18.8% |
| 2017 FY | 380.26 Million MYR | -12.05% |
| 2017 Q4 | 101.25 Million MYR | 8.84% |
| 2017 Q3 | 93.03 Million MYR | -10.72% |
| 2017 Q2 | 104.2 Million MYR | 14.6% |
| 2016 FY | 432.34 Million MYR | 18.54% |
| 2016 Q1 | 164.45 Million MYR | 21.67% |
| 2016 Q3 | 74.99 Million MYR | -43.76% |
| 2016 Q4 | 76.53 Million MYR | 2.05% |
| 2016 Q2 | 133.34 Million MYR | -18.92% |
| 2015 Q4 | 135.16 Million MYR | 33.1% |
| 2015 Q3 | 101.54 Million MYR | 42.87% |
| 2015 Q2 | 71.07 Million MYR | 18.6% |
| 2015 FY | 364.72 Million MYR | 82.23% |
| 2015 Q1 | 59.92 Million MYR | 14.39% |
| 2014 Q3 | 55.57 Million MYR | 9.96% |
| 2014 Q2 | 50.53 Million MYR | -19.18% |
| 2014 Q1 | 62.52 Million MYR | -7.55% |
| 2014 FY | 200.14 Million MYR | -14.1% |
| 2014 Q4 | 52.38 Million MYR | -5.73% |
| 2013 FY | 232.98 Million MYR | -3.25% |
| 2013 Q2 | 61.44 Million MYR | -12.73% |
| 2013 Q4 | 67.62 Million MYR | 55.66% |
| 2013 Q1 | 70.41 Million MYR | 5.64% |
| 2013 Q3 | 43.44 Million MYR | -29.3% |
| 2012 Q3 | 63.71 Million MYR | -7.43% |
| 2012 FY | 240.81 Million MYR | 79.42% |
| 2012 Q1 | 41.61 Million MYR | -39.56% |
| 2012 Q2 | 68.82 Million MYR | 65.37% |
| 2012 Q4 | 66.65 Million MYR | 4.62% |
| 2011 Q3 | 34.58 Million MYR | 9.69% |
| 2011 Q4 | 68.86 Million MYR | 99.13% |
| 2011 Q2 | 31.52 Million MYR | 0.0% |
| 2011 FY | 134.22 Million MYR | -56.08% |
| 2010 FY | 305.6 Million MYR | 32.57% |
| 2009 FY | 230.52 Million MYR | 58.23% |
| 2008 FY | 145.68 Million MYR | 10.23% |
| 2007 FY | 132.16 Million MYR | 30.44% |
| 2006 FY | 101.32 Million MYR | 43.88% |
| 2005 FY | 70.42 Million MYR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | 46311.369% |
| Ansell Limited | 129.3 Million USD | 516.088% |
| Ansell Limited | 129.3 Million USD | 516.088% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 1827.788% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | -33615.715% |
| Psykey, Inc. | -797.5 Thousand USD | -67360.727% |
| ConvaTec Group Plc | 262.7 Million USD | 304.797% |
| ConvaTec Group Plc | 262.7 Million USD | 304.797% |
| Encision Inc. | -640.78 Thousand USD | -83860.093% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -379282.272% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -489304.166% |
| Innovative MedTech Inc. | -4.27 Million USD | -12487.563% |
| LifePoint, Inc. | -7.49 Million USD | -7077.927% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | -8202.5% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | 163130.909% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | -437691.521% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | -115035.316% |
| SmileDirectClub, Inc. | -241.15 Million USD | -123.093% |
| Sector 10, Inc. | -39.84 Thousand USD | -1350171.057% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 268.332% |
| SheerVision, Inc. | 155.72 Thousand USD | 345579.881% |
| United Health Products, Inc. | -2.42 Million USD | -22071.579% |
| Vasamed, Inc. | 4.74 Million USD | 11444.744% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | -23351.131% |
| Yubo International Biotech Limited | -1.2 Million USD | -44539.208% |